Insider · CIK 0001635616

Brockstedt Dirk G.

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001635616

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−7,000 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−3,125 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−1,225 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−9,375 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−58.3K sh	—	—	41,667
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−1,035 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−2,500 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−6,250 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−6,876 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc.U Disposition from Tender	CHIEF SCIENTIFIC OFFICER	UDisposition from Tender	−4,648 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−64.4K sh	—	—	0
2025-06-20	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+100K sh	—	—	100,000
2025-01-30	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+515K sh	—	—	515,000
2024-01-31	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+75K sh	—	—	75,000
2024-01-05	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−898 sh	$22.78	−$20.5K	27,820
2023-12-29	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+8,000 sh	—	—	7,690
2023-12-29	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+8,000 sh	$6.18	+$49.4K	27,070
2023-01-31	RAPTRAPT Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+56K sh	—	—	56,000
2023-01-05	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−742 sh	$21.97	−$16.3K	19,070
2022-05-04	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−720 sh	$15.05	−$10.8K	19,812
2022-04-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,290 sh	—	—	2,113
2022-04-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,647 sh	$23.05	−$61K	19,812
2022-04-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,647 sh	$6.18	+$16.4K	22,459
2022-04-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,357 sh	—	—	15,690
2022-03-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,648 sh	—	—	17,047
2022-03-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,648 sh	$23.91	−$63.3K	19,812
2022-03-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,648 sh	$6.18	+$16.4K	22,460
2022-02-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,647 sh	—	—	19,695
2022-02-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,647 sh	$22.47	−$59.5K	19,812
2022-02-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,647 sh	$6.18	+$16.4K	22,459
2022-01-28	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+55K sh	—	—	55,000
2022-01-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,648 sh	$6.18	+$16.4K	22,460
2022-01-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,648 sh	$32.16	−$85.2K	19,812
2022-01-11	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,648 sh	—	—	22,342
2022-01-03	RAPTRAPT Therapeutics, Inc.F Tax Payment	CHIEF SCIENTIFIC OFFICER	FTax Payment	−820 sh	$36.73	−$30.1K	18,992
2021-12-10	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,647 sh	$6.30	+$16.7K	22,459
2021-12-10	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,647 sh	$30.88	−$81.7K	19,812
2021-12-10	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,647 sh	—	—	611
2021-11-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,648 sh	—	—	3,258
2021-11-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,648 sh	$35.69	−$94.5K	19,812
2021-11-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,648 sh	$6.30	+$16.7K	22,460
2021-10-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,647 sh	—	—	24,990
2021-10-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,647 sh	$30.78	−$81.5K	19,812
2021-10-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,647 sh	$6.18	+$16.4K	22,459
2021-09-10	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,648 sh	—	—	27,637
2021-09-10	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,648 sh	$35.78	−$94.7K	19,812
2021-09-10	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,648 sh	$6.18	+$16.4K	22,460
2021-08-11	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+2,647 sh	$6.18	+$16.4K	22,459
2021-08-11	RAPTRAPT Therapeutics, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,647 sh	$31.19	−$82.6K	19,812
2021-08-11	RAPTRAPT Therapeutics, Inc. · Option (right to buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,647 sh	—	—	30,285

Recent filings

Accepted (ET)
Mar 54
Brockstedt Dirk G.0001635616-26-000001
SEC(opens sec.gov)
Jun 244
Brockstedt Dirk G.0001415889-25-018062
SEC(opens sec.gov)
Feb 34
Brockstedt Dirk G.0001415889-25-002800
SEC(opens sec.gov)
Feb 14
Brockstedt Dirk G.0001415889-24-002223
SEC(opens sec.gov)
Jan 84
Brockstedt Dirk G.0001415889-24-000817
SEC(opens sec.gov)
Jan 24
Brockstedt Dirk G.0001593968-24-000003
SEC(opens sec.gov)
Feb 24
Brockstedt Dirk G.0001209191-23-006354
SEC(opens sec.gov)
Jan 94
Brockstedt Dirk G.0001593968-23-000096
SEC(opens sec.gov)
May 54
Brockstedt Dirk G.0001593968-22-000920
SEC(opens sec.gov)

Companies

Address

C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE

SOUTH SAN FRANCISCO, CA, 94080